WEDBUSH SECURITIES INC - CANCER GENETICS INC ownership

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q1 2019$6,000
-33.3%
24,022
-37.7%
0.00%0.0%
Q4 2018$9,000
-82.7%
38,532
-22.2%
0.00%
-83.3%
Q3 2018$52,000
+10.6%
49,532
-5.3%
0.01%0.0%
Q2 2018$47,000
-40.5%
52,310
+9.4%
0.01%
-40.0%
Q1 2018$79,000
-10.2%
47,8000.0%0.01%
-9.1%
Q4 2017$88,000
-31.8%
47,8000.0%0.01%
-35.3%
Q3 2017$129,000
-45.8%
47,800
-20.7%
0.02%
-45.2%
Q2 2017$238,000
-33.3%
60,300
-30.7%
0.03%
-35.4%
Q1 2017$357,000
+192.6%
87,000
-3.9%
0.05%
+166.7%
Q4 2016$122,00090,5000.02%
Other shareholders
CANCER GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 581,200$1,157,0001.33%
Fairbanks Capital Management, Inc. 233,170$464,0000.56%
DIKER MANAGEMENT LLC 29,815$59,0000.02%
SABBY MANAGEMENT, LLC 199,580$397,0000.02%
Sterneck Capital Management, LLC 14,750$29,0000.02%
Spot Trading L.L.C 151,900$302,0000.01%
Acrospire Investment Management LLC 3,514$7,0000.01%
EAGLE GLOBAL ADVISORS LLC 84,320$168,0000.01%
BECK MACK & OLIVER LLC 18,225$36,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 47,600$94,0000.00%
View complete list of CANCER GENETICS INC shareholders